ArticleCureus2026

The Effect of Bevacizumab Therapy on Reducing Erythrocyte Transfusion Requirements and Preventing Iron Deficiency in Patients With Hereditary Hemorrhagic Telangiectasia.

Öznur Aydın et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.